Madrigal Pharmaceuticals has significantly bolstered its pipeline for metabolic dysfunction-associated steatohepatitis (MASH) by acquiring the global rights to Arrowhead Pharmaceuticals’…
Read More
Ludwig Cancer Research Study Reveals Novel Combination Therapy for Acute Myelogenous Leukemia Targeting LSD1 and GSK3 Enzymes
In a significant advancement for hematological oncology, researchers from Ludwig Cancer Research have identified a promising new therapeutic strategy to…
Read More
LEO Pharma Acquires Gene Therapy Pioneer Replay to Revolutionize Treatment for Rare Genetic Dermatological Diseases
In a landmark move poised to redefine the landscape of dermatological therapeutics, LEO Pharma, a global leader in medical dermatology,…
Read More
Creating early career opportunities for advanced therapy manufacturing and development
The RESILIENCE Skills program, a comprehensive UK-wide initiative, is actively addressing a critical talent deficit in advanced medicines manufacturing, a…
Read More
Rising Therapy-Related Leukemia Rates Signal New Testing Demands for Clinical Labs
The landscape of cancer care is undergoing a profound transformation, marked by significant advancements in diagnostics and therapeutics that have…
Read More
Regeneron cuts White House pricing deal, offers new gene therapy for free – Pharmaceutical Technology
Regeneron Pharmaceuticals has entered into a significant drug pricing agreement with the White House, marking a pivotal moment in the…
Read More
Breakthrough Combination Therapy Offers New Hope for Acute Myelogenous Leukemia Treatment through Epigenetic Reprogramming
Acute myelogenous leukemia (AML) remains one of the most formidable challenges in modern oncology, characterized by a rapid progression and…
Read More
Nature-Inspired Precision: International Study Unveils Targeted Gene Therapy Delivery Using Specific Extracellular Vesicles
A groundbreaking international study, spearheaded by researchers from the University of Ottawa Faculty of Medicine in Canada, has introduced a…
Read More
Innovative Gene Therapy Targets Chronic Pain Circuits Without Addiction Risk in Landmark Preclinical Study
In a significant advancement for neurobiology and pain management, researchers from the University of Pennsylvania, Stanford University, and Carnegie Mellon…
Read More
Rising Therapy-Related Leukemia Rates Signal New Testing Demands for Clinical Labs
The landscape of cancer care is undergoing a profound transformation, marked by significant advancements in treatment modalities that have dramatically…
Read MoreYOU MAY HAVE MISSED
